Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.980
-0.090 (-8.41%)
Jan 21, 2025, 4:00 PM EST - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $39.42 million as of January 21, 2025. Its market cap has decreased by -71.72% in one year.
Market Cap
39.42M
Enterprise Value
-54.01M
1-Year Change
-71.72%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $39.42M, a decrease of -93.19%. That is a compound annual growth rate of -51.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 41.84M | -13.91% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |